AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 176 filers reported holding AXSOME THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.46 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $1,706,000 | +14.5% | 35,116 | +33.4% | 0.00% | 0.0% |
Q1 2021 | $1,490,000 | -36.5% | 26,316 | -8.7% | 0.00% | -33.3% |
Q4 2020 | $2,348,000 | +28.7% | 28,816 | +12.5% | 0.00% | 0.0% |
Q3 2020 | $1,825,000 | -13.4% | 25,616 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $2,108,000 | +110.6% | 25,616 | +50.5% | 0.00% | +50.0% |
Q1 2020 | $1,001,000 | -75.4% | 17,016 | -56.8% | 0.00% | -66.7% |
Q4 2019 | $4,074,000 | +455.8% | 39,416 | +8.9% | 0.01% | +500.0% |
Q3 2019 | $733,000 | +7.5% | 36,200 | +36.6% | 0.00% | 0.0% |
Q2 2019 | $682,000 | – | 26,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,123,929 | $42,462,000 | 36.04% |
MORGAN JESS S & CO INC | 114,525 | $4,327,000 | 2.66% |
Fairmount Funds Management LLC | 187,598 | $7,087,000 | 2.34% |
WMS Partners, LLC | 242,500 | $9,162,000 | 1.95% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 610,064 | $23,048,000 | 1.41% |
MANGROVE PARTNERS IM, LLC | 400,000 | $15,112,000 | 0.90% |
RTW INVESTMENTS, LP | 1,618,819 | $61,159,000 | 0.89% |
MPM BioImpact LLC | 103,405 | $3,907,000 | 0.71% |
Avidity Partners Management LP | 775,000 | $29,280,000 | 0.62% |
FIRST MIDWEST BANK TRUST DIVISION | 115,028 | $4,346,000 | 0.56% |